Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-08

Clinical Trial Update: Efficacy and Safety of Blue Light (453 nm) Treatment for Mild Psoriasis Vulgaris Over Three Months Compared to Vitamin D. [NA]

View source ↗

Summary

A completed clinical trial evaluating efficacy and safety of blue light 453 nm treatment for mild psoriasis vulgaris over three months versus vitamin D, with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Blue Light (453 nm) treatment
  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: Philips Electronics Nederland BV | Conditions: Psoriasis Vulgaris | NA | Status: COMPLETED | Results posted: 2019-01-08